Response to “In vivo secretion of anti-CD3 × anti-tumor bispecific antibodies by gene-modified cells: over a decade of T-cell engagement”

Benzer Materyaller

• In vivo secretion of anti-CD3 × anti-tumor bispecific antibodies by gene-modified cells: over a decade of T-cell engagement
  Yazar:: Compte, Marta, ve diğerleri
  Baskı/Yayın Bilgisi: (2015)
• Human endoglin-CD3 bispecific T cell engager antibody induces anti-tumor effect in vivo
  Yazar:: Zhong, Liping, ve diğerleri
  Baskı/Yayın Bilgisi: (2021)
• Antitumor activity of T cells secreting αCD133-αCD3 bispecific T-cell engager against cholangiocarcinoma.
  Yazar:: Thanich Sangsuwannukul, ve diğerleri
  Baskı/Yayın Bilgisi: (2022-01-01)
• Costimulatory T cell engagement via a novel bispecific anti-CD137 /anti-HER2 protein
  Yazar:: Hinner, Marlon J, ve diğerleri
  Baskı/Yayın Bilgisi: (2015)
• T cells expressing CD19-specific Engager Molecules for the Immunotherapy of CD19-positive Malignancies
  Yazar:: Velasquez, Mireya Paulina, ve diğerleri
  Baskı/Yayın Bilgisi: (2016)